Efficacy of Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis in the North American Subgroup of Patients: Pooled Analysis of Four Phase 3 Studies

INTRODUCTION: Demographic and disease characteristics may impact response to psoriasis therapies. The objective of this study is to explore the safety and efficacy profile of secukinumab in North American (NA) versus non-NA patients with moderate to severe psoriasis. METHODS: Data were pooled from f...

Descripción completa

Detalles Bibliográficos
Autores principales: Pariser, David, Frankel, Ellen, Schlessinger, Joel, Poulin, Yves, Vender, Ronald, Langley, Richard G., Meng, Xiangyi, Guana, Adriana, Nyirady, Judit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5825316/
https://www.ncbi.nlm.nih.gov/pubmed/29218492
http://dx.doi.org/10.1007/s13555-017-0211-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5825316/
https://www.ncbi.nlm.nih.gov/pubmed/29218492
http://dx.doi.org/10.1007/s13555-017-0211-4

Ejemplares similares